| Issue |
Title |
File |
| Vol 22, No 2 (2020) |
Biobanks in oncology: global experience and Russian reality |
(Rus)
|
|
Kaprin A.D., Ivanov S.A., Petrov V.A., Dukhova N.N., Dvinskikh N.I., Falaleeva N.A., Grivtsova L.I.
|
| Vol 18, No 2 (2016) |
Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study |
(Rus)
|
|
Ignatova E.O., Burdaeva O.N., Kopp M.V., Kotiv B.N., Udovitsa D.P., Stroiakovskii D.L., Alekseev S.M., Sheveleva L.P., Khorinko A.V., Shapovalova I.S., Moiseenko V.M., Ivanov R.A.
|
| Vol 23, No 2 (2021) |
Biological features of ductal carcinoma in situ: clinical role and basis for treatment individualization |
(Rus)
|
|
Kolyadina I.V., Butrimova A.S., Poddubnaya I.V., Kоmetova V.V., Rodionov V.V.
|
| Vol 7, No 2 (2005) |
Biologicheskie kharakteristiki opukholi (proliferativnaya aktivnost', ploidnost' i steroidnye retseptory) i ikh vliyanie na neposredstvennye i otdalennye rezul'taty lecheniya zapushchennogo raka molochnoy zhelezy |
|
|
Nikolaeva T.G., Vyshinskaya G.V., Rotobel'skaya L.E.
|
| Vol 13, No 4 (2011) |
Biosimilyary: novye vozmozhnostisovremennoy lekarstvennoy terapiiopukholey |
|
|
Poddubnaya I.V.
|
| Vol 27, No 1 (2025) |
Blood management of patients with stage II–III colorectal cancer: Results of a comparative study |
(Rus)
|
|
Lyadov V.K., Kornev D.O., Moskalenko A.N., Galkin V.N.
|
| Vol 24, No 2 (2022) |
Blood thinners for the initial treatment of blood clots in people with cancer |
(Rus)
|
|
Ziganshin A.U.
|
| Vol 10, No 3 (2008) |
Bondronat v forme dlya priema vnutr' effektiven u bol'nykh s kostnymi metastazami raka molochnoy zhelezy. Opyt odnogo tsentra |
|
|
Semenov N.N., Lichinitser M.R., Vyshinskaya G.V., Meshcheryakov A.A., Novikov V.V., Gutorov S.L., Borisova E.I., Nakhalova T.A., Mikhina Z.P., Lyubimova N.V., Chaklina E.A., Aplevich N.N.
|
| Vol 15, No 4 (2013) |
Bone mineral density in patient with breast cancer |
|
|
Poddubnaya I.V., Kizhaev E.V., Kolyadina I.V., Banov S.M., Zhmaeva E.M., Secko M.A.
|
| Vol 19, No 2 (2017) |
Brachytherapy with ultrasound assistance in patients with cervical cancer |
(Rus)
|
|
Kizhaev Y.E., Razumova E.L., Bessolova O.V.
|
| Vol 17, No 2 (2015) |
Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy |
|
|
Artamonova E.V., Manziuk L.V.
|
| Vol 18, No 1 (2016) |
BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia) |
(Rus)
|
|
Khokhlova S.V., Gorbunova V.A., Lyubchenko L.N., Imyanitov E.N.
|
| Vol 23, No 1 (2021) |
Breast cancer |
(Rus)
|
|
Zhukova L.G., Andreeva I.I., Zavalishina L.E., Zakiriakhodzhaev A.D., Koroleva I.A., Nazarenko A.V., Paltuev R.M., Parokonnaia A.A., Petrovskii A.V., Portnoi S.M., Semiglazov V.F., Semiglazova T.I., Stenina M.B., Stepanova A.M., Trofimova O.P., Tyulyandin S.A., Frank G.A., Frolova M.A., Shatova I.S., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
|
| Vol 17, No 1 (2015) |
Breast cancer immunology: theory and prospects (review) |
|
|
Kolyadina I.V., Poddubnaya I.V.
|
| Vol 23, No 2 (2021) |
Breast cancer immunophenotype and its relationship with haematopoiesis |
(Rus)
|
|
Ryabchikov D.A., Chulkova S.V., Shamilov F.A., Chanturia N.V., Zheltikov S.D., Tupitsyn N.N.
|
| Vol 15, No 2 (2013) |
Breast cancer: from guidelines to personalized oncology |
|
|
PierFranco C., Valentina G.
|
| Vol 25, No 2 (2023) |
Breast cancer: genetic personal risk factors: A review |
(Rus)
|
|
Zolotykh M.A., Bilyalov A.I., Nesterova A.I., Gimranov A.M., Filina J.V., Rizvanov A.A., Miftakhova R.R.
|
| Vol 18, No 2 (2016) |
Brentuximab vedotin in the treatment of relapsed and refractory forms of Hodgkin lymphoma |
(Rus)
|
|
Demina E.A.
|
| Vol 15, No 4 (2013) |
Brest cancer: international online cooperation on sharing experience |
|
|
- -.
|
| Vol 2, No 3 (2000) |
Bronkhoskopiya v diagnostike i lechenii opukholey trakheobronkhial'nogo stvola |
|
|
Poddubnyy B.K., Ungiadze G.V., Belousova N.V., Polotskiy B.E., Kontsevaya A.Y., Alekseeva T.R., Kondrat'eva T.T.
|
| Vol 23, No 3 (2021) |
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer |
(Rus)
|
|
Ognerubov N.A.
|
| Vol 24, No 2 (2022) |
Cabozantinib in the treatment of patients with advanced renal cell carcinoma |
(Rus)
|
|
Volkova M.I., Turupaev K.A., Kalinin S.A.
|
| Vol 23, No 3 (2021) |
Can any breast skin thickening be staged as T4? |
(Rus)
|
|
Amosova V.A., Petrovskii A.V., Karpova M.S., Ponedel’nikova N.V., Frolova M.A.
|
| Vol 25, No 4 (2023) |
Can bispecific antibodies change the paradigm and goals of therapy for patients with relapsed non-Hodgkin lymphomas? |
(Rus)
|
|
Poddubnaya I.V.
|
| Vol 25, No 1 (2023) |
Can musical interventions benefit patients with cancer? |
(Rus)
|
|
Razumovskaya E.A.
|
| Vol 22, No 4 (2020) |
Cancer of an ectopic parathyroid gland: from diagnosis to treatment (clinical case) |
(Rus)
|
|
Allakhverdiev A.K., Malkina N.A., Noskova K.K., Grinevich V.N., Feidorov I.Y., Ketsba A.F., Bystrovskay E.V., Embutniex Y.V., Putova M.V., Synkova D.A.
|
| Vol 22, No 2 (2020) |
Cancer patient management during the COVID-19 pandemic Training module. Version 2 from 30.04.2020 |
(Rus)
|
|
Poddubnaya I.V., Sychev D.A., Abuzarova G.R., Allakhverdiev A.K., Arkhiri P.P., Babicheva L.G., Baranova M.P., Volkova M.I., Ignatova A.V., Kashurnikov A.I., Kniazev R.I., Kolyadina I.V., Komarov I.G., Kriukov A.V., Levitskaia N.V., Liadov V.K., Malikhova O.A., Nered S.N., Orel N.F., Podviaznikov S.O., Sagaidak I.V., Sarmanaeva R.R., Stilidi I.S., Trofimova O.P., Tumian G.S., Kharitonova T.V.
|
| Vol 27, No 2 (2025) |
Cancer-associated thrombosis: pathogenesis, risk factors, and treatment. A review |
(Rus)
|
|
Bilyalov A.I., Nesterova A.I., Bodunova N.A., Zinchenko S.V.
|
| Vol 24, No 3 (2022) |
CAR NK-сells for the treatment of hematological malignancies: A review |
(Rus)
|
|
Gribkova I.V.
|
| Vol 26, No 2 (2024) |
Cardiovascular toxicity of chemotherapy and thyroid status of patients with gastric and colon cancer: Current state of the problem. A review |
(Rus)
|
|
Stanoevich I.V., Ioutsi V.A., Lysovolenko N.L., Alekseev I.E., Kondrashkina A.D., Polianskii M.B., Pis'mennaia E.V.
|
| Vol 20, No 2 (2018) |
Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer |
(Rus)
|
|
Frolova M.A., Kochetkova Y.I., Chubenko V.A., Volkov N.M., Moiseenko F.V., Garmarnik T.V., Ponomarenko D.M., Orlov A.E., Kostalanova Y.V., Makarycheva Y.Y., Nizegorodzeva A.A.
|
| Vol 20, No 3 (2018) |
Catamnesis of pediatric thoracic and abdominal cancer survivours |
(Rus)
|
|
Mikhailova S.N., Zaeva G.E., Gavrilenko T.F., Sinyagina Y.V., Kazantsev A.P.
|
| Vol 25, No 2 (2023) |
Challenges and perspectives of first-line therapy in patients with diffuse B-cell lymphoma: A review |
(Rus)
|
|
Babicheva L.G., Poddubnaya I.V.
|
| Vol 18, No 5 (2016) |
Characteristics of approach to the treatment of chronic pain in terminal cancer patients |
|
|
Nevzorova D.V., Ibragimov A.N., Bakunina E.A.
|
| Vol 25, No 1 (2023) |
Characteristics of the receptor phenotype of tumor-associated immune cells of the epithelial-mesenchymal microenvironment of ovarian cancer |
(Rus)
|
|
Zhurman V.N.
|
| Vol 17, No 3 (2015) |
Choice of anti-angiogenic agents in second-line treatment in patients with metastatic colon cancer: bevacizumab, aflibercept, ramucirumab (a literature review) |
|
|
Fedyanin M.I.
|
| Vol 22, No 3 (2020) |
Chronic lymphocytic leukemia/small lymphocytic lymphoma |
(Rus)
|
|
Nikitin E.A., Bialik T.E., Zaritskii A.I., Iseber L., Kaplanov K.D., Lopatkina T.N., Lugovskaia S.A., Mukhortova O.V., Osmanov E.A., Poddubnaya I.V., Samoilova O.S., Stadnik E.A., Falaleeva N.A., Baikov V.V., Kovrigina A.M., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
|
| Vol 23, No 3 (2021) |
Circulating and disseminated tumor cells as a possible prognostic factor for oncological diseases |
(Rus)
|
|
Kaprin A.D., Zatsarenko S.V., Ivanov S.A., Grivtsova L.Y.
|
| Vol 18, No 3 (2016) |
Circulating tumor cell: biology, methods of isolation, clinical significance in breast cancer |
(Rus)
|
|
Nenahova Y.N., Lyadov V.K., Poddubnaya I.V.
|
| Vol 24, No 3 (2022) |
Classification of breast cancer subtypes based on RNA profiling and immunohistochemical methods: clinical and biological aspects: A review |
(Rus)
|
|
Imyanitov E.N.
|
| Vol 25, No 3 (2023) |
Clinical and economic benefits of parenteral iron carboxymaltosate in patients with gynecological cancers: A retrospective observational study |
(Rus)
|
|
Saevets V.V., Shamanova A.Y.
|
| Vol 23, No 3 (2021) |
Clinical and morphological case of lung cancer with generalized metastases to the internal organs |
(Rus)
|
|
Vorobeva O.V.
|
| Vol 24, No 1 (2022) |
Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study |
(Rus)
(Eng)
|
|
Sokolova T.N., Solov'eva T.I., Aleksakhina S.N., Janus G.A., Goryainova A., Gluzman M.I., Orlova R.V., Stukan A.I., Zukov R.A., Zyuzyukina A.V., Murunova Y.N., Sultanbaev A.V., Vorobeva E.N., Mikhaevich L.M., Pyliv V.N., Lysenko A.N., Khachmamuk Z.K., Kozlov A.E., Bakharev S.Y., Parsyan S.G., Rossokha E.I., Osidze L.D., Shumskaya I.S., Agaeva A.V., Kasmynina T.A., Klimenko V.V., Akhmetgareeva K.T., Vakhitova A.A., Chakhkieva M.D., Dmitriev V.N., Bakshun Y.I., Vasilyev A.E., Gasimly D.D., Kravchenko N.A., Maksimov D.A., Nesterova A.I., Sharvashidze I.O., Gadzaova C.H., Rakhmankulova G.G., Khamgokov Z.M., Amirkhanova I.K., Bembeeva L.V., Vladimirov V.I., Petrenko O. ., Ruskova N.G., Serikova E.L., Subbotina K.S., Tkachenko S.A., Chang V.L., Erdniev S.P., Barbara V.S., Vasilevskaya A.V., Mikheeva Y.V., Popova N.O., Startseva E.P., Fateeva A.V., Yukalchuk D.Y., Grechkina A.A., Musaeva K.S., Odintsova S.V., Stel'makh A.S., Khabibulaeva P.I., Khlobystina A.G., Shvaiko K.A., Basova E.A., Bogomolova I.A., Bolieva M.B., Goldberg V.E., Kibisheva M.V., Menshikov K.V., Ryazanov D.V., Stepanova M.L., Udalova Y.A., Shkradyuk A.V., Chapko Y.S., Shchukina A.A., Khabriev I.M., Kirtbaya D.V., Degtyarev A.M., Epkhiev A.A., Tyugina Y.A., Murachuev M.A., Togo A.V., Ievleva A.G., Imyanitov E.N.
|
| Vol 17, No 3 (2015) |
Clinical and prognostic significance of matrix metalloproteinase-7 and vascular endothelium growth factor in patients with ovarian cancer |
|
|
Knyazev R.I., Poddubnaya I.V., Bokin I.I., Barinov V.V.
|
| Vol 19, No 4 (2017) |
Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0 |
(Rus)
|
|
Pavlikova O.A., Poddubnaya I.V., Kolyadina I.V., Abdullaev A.G., Komov D.V., Danzanova T.Y., Sinyukova G.T., Kozlov N.A., Ganshina I.P., Zhukova L.G., Aliyeva G.S., Kerimov R.A., Gordeeva O.O.
|
| Vol 26, No 2 (2024) |
Clinical benefits of parenteral iron carboxymaltose in patients with colorectal cancer: a retrospective observational study |
(Rus)
|
|
Postolov M.P., Suvorov V.A., Kravets A.V.
|
| Vol 16, No 4 (2014) |
Clinical case long-term care of the patient with mCRPC |
|
|
Zaborskiy I.N., Karjakin O.B.
|
| Vol 25, No 1 (2023) |
Clinical case of complications of immunotherapy – encephalitis |
(Rus)
|
|
Lyadova M.A., Kuchevskaya O.A., Kulikova E.A.
|
| Vol 22, No 2 (2020) |
Clinical case of long-term use of durvalumab in the treatment of advanced small-cell lung cancer |
(Rus)
|
|
Statsenko G.B., Kurakin V.I., Plokhotenko I.V.
|
| Vol 22, No 2 (2020) |
Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma |
(Rus)
|
|
Odintsova S.V., Sviridenko M.A., Cheremnykh A.O., Filippova E.A., Urtenova M.A., Orlov S.V.
|
| Vol 19, No 4 (2017) |
Clinical cases of the treatment of metastatic colorectal cancer in Russia |
(Rus)
|
|
Goldberg V.E., Hasanova A.I., Shkuratova V.V., Belevich Y.V., Popova N.O., Simolina E.I., Vysockaya V.V., Dudnikova E.A., Kravchuk T.L., Minnabetdinova R.R., Nekrasova O.V.
|
| Vol 16, No 1 (2014) |
Clinical cases of treatment of hepatocellular carcinoma |
|
|
Lazarev S.A., Mamontov K.G., Manihas G.M., Antimonik N.Y.
|
| Vol 20, No 1 (2018) |
Clinical cases of treatment of patients with advanced hepatocellular carcinoma |
(Rus)
|
|
Petkau V.V., Gladkov O.A., Filatov P.N., Raigorodskii M.V., Tarkhanov A.A., Klimushkin A.V., Nikitina L.Y.
|
| Vol 15, No 4 (2013) |
Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney |
|
|
Klimenko A.A., Ivanov S.A.
|
| Vol 16, No 3 (2014) |
Clinical experience with abiraterone acetate application in patients with castration-resistant prostate cancer |
|
|
Gridneva Y.V., Matveev V.B., Kupchan D.Z., Kalinin S.A., Peters M.V.
|
| Vol 25, No 1 (2023) |
Clinical factors of the risk of hyperplastic endometry processes on tamoxifen therapy with breast cancer: Retrospective population study |
(Rus)
|
|
Golubenko E.O., Savelyeva M.I., Poddubnaya I.V., Korennaya V.V.
|
| Vol 18, No 5 (2016) |
Clinical features and therapy of double-hit and double-expressor lymphomas |
|
|
Baryakh E.A., Misyurina A.E., Kovrigina A.M., Obukhova T.N., Kravchenko S.K., Magomedova A.U., Zingerman B.V., Misyurina E.N., Poteshkina N.G., Lysenko M.A., Vorobev A.I.
|
| Vol 20, No 3 (2018) |
Clinical prognostic factors of bilateral synchronous renal cancer |
(Rus)
|
|
Komarov M.I., Matveev V.B., Volkova M.I., Komarov I.G., Ridin V.A.
|
| Vol 26, No 3 (2024) |
Clinical significance of PET/CT in the diagnosis of primary adrenal malignancies |
(Rus)
|
|
Ognerubov N.A., Antipova T.S., Mirsalimova O.O., Poddubnaya I.V.
|
| Vol 20, No 1 (2018) |
Clinical significance of the achievement of MRD-negativity in patients with chronic lymphocytic leukemia |
(Rus)
|
|
Mirolyubova Y.V., Stadnik E.A.
|
| Vol 25, No 2 (2023) |
Clinical significance of the pathological type of tumor in common forms of ovarian cancer: A retrospective study |
(Rus)
|
|
Zhurman V.N.
|
| Vol 18, No 3 (2016) |
Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene |
(Rus)
|
|
Ryazhenov V.V., Gorokhova S.G.
|
| Vol 19, No 2 (2017) |
Clinico-morphological predictors and treatment outcomes in cervical stump cancer |
(Rus)
|
|
Usmanova L.S., Kuznetsov V.V., Mustafina E.A., Barinov V.V., Bokin I.I., Knyazev R.I., Akhmedova M.D.
|
| Vol 25, No 3 (2023) |
Colon cancer-induced sarcopenia: clinical and radiological correlations |
(Rus)
|
|
Lyadov V.K., Fedorinov D.S., Lyadova M.A., Khristenko E.A., Boldyreva T.S., Galkin V.N.
|
| Vol 25, No 1 (2023) |
Combination of encorafenib and binimetinib in the treatment of patients with BRAF-mutated advanced melanoma. Case report |
(Rus)
|
|
Orlova K.V., Petenko N.N., Garanina N.V., Demidov L.V.
|
| Vol 24, No 4 (2022) |
Combination of microspheres and gadoteridol for the determination of non-target ovarian embolization during uterine artery embolization. A case series |
(Rus)
|
|
Sharafutdinov B.M., Ryzhkin S.A., Galim'yanov D.A., Gaziev E.A.
|
| Vol 24, No 2 (2022) |
Combination therapy regimens in the treatment of metastatic renal cell carcinoma: A review |
(Rus)
|
|
Zukov R.A., Chernyaev D.V., Zulkaidarova A.R.
|
| Vol 15, No 1 (2013) |
Combined and complex treatment options for patients with operable rectal cancer |
|
|
Barsukov Y.A., Tkachev S.I., Mamedli Z.Z., Kuzmichev D.V., Aliev В.А., Kim D.F.
|
| Vol 25, No 4 (2023) |
Comorbid pathology in SARS-CoV-2 infected in cancer practice as a predictor of severe outcomes in COVID-19. COVID-19 prognostic online risk assessment tool in oncology: A retrospective study |
(Rus)
|
|
Sekacheva M.I., Rusanov A.S., Kokhanovskaia I.I.
|
| Vol 26, No 3 (2024) |
Comparative analysis of efficacy and safety of combined immunotherapy and immune targeted therapy in the first-line treatment of advanced renal cell carcinoma: a real-world study |
(Rus)
|
|
Pokataev I.A., Stativko O.A., Volkova M.I., Fedorova A.N., Zueva E.V., Ibragimova M.R., Tsareva E.V., Antonova T.G., Sinitsyna O.R., Cherniaev V.A., Gridneva Y.V., Oskarev A.V., Galkin V.N.
|
| Vol 22, No 3 (2020) |
Comparative analysis of the effectiveness of «Chaos and Clues», «Triage Amalgamated Dermoscopic Algorithm» dermatoscopic algorithms and BLINСK techniques in the diagnosis of melanoma and other skin cancers depending on previous dermatoscopy experience |
(Rus)
|
|
Silina L.V., Khvostovoi V.V., Ovsianikov V.V., Zubtsov M.S.
|
| Vol 23, No 4 (2021) |
Comparative analysis results of surgical treatment, chemoradiotherapy and chemotherapy with assessment of prognostic factors in cervical esophageal cancer |
(Rus)
|
|
Radzhabova Z.A., Kotov M.A., Girshovich M.M., Ponomareva O.I., Tkachenko E.V., Mitrofanov A.S., Radzhabova M.A., Levchenko E.V.
|
| Vol 17, No 4 (2015) |
Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas |
|
|
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
|
| Vol 23, No 3 (2021) |
Comparison of afatinib and osimertinib effect on overall survival in first-line drug treatment of EGFR-positive metastatic non-small cell lung cancer: network meta-analysis |
(Rus)
|
|
Goryaynov S.V.
|
| Vol 26, No 3 (2024) |
Comparison of efficacy and safety of regorafenib and anti-EGFR targeted therapy in metastatic colorectal cancer: A retrospective study |
(Rus)
|
|
Kuzmina E.S., Fedyanin M.Y., Lyadova M.A., Fedorinov D.S., Polyanskiy M.A., Parts S.A., Pokataev I.A., Galkin V.N.
|
| Vol 23, No 1 (2021) |
Comparison of the efficacy of first-line therapy with different generations of EGFR tyrosine kinase inhibitors in patients with advanced EGFR-associated non-small cell lung cancer: a network meta-analysis of overall survival data |
(Rus)
|
|
Bogdanov A.A., Moiseenko F.V., Egorenkov V.V., Bogdanov A.A., Volkov N.M., Fedyanin M.Y.
|
| Vol 26, No 3 (2024) |
Comparison of the efficacy of neoadjuvant chemotherapy with FLOT regimen and adjuvant chemotherapy with XELOX/FOLFOX regimen in patients with locally advanced gastric cancer: A retrospective study |
(Rus)
|
|
Semenov N.N., Izrailov R.E., Semenov N.E., Zhukova L.G., Feoktistova P.S., Matveychuk D.A., Khatkov I.E.
|
| Vol 21, No 3 (2019) |
Complex radiologic imaging of early breast cancer (literature review) |
(Rus)
|
|
Aliyeva G.S., Korzhenkova G.P., Kolyadina I.V.
|
| Vol 24, No 1 (2022) |
Comprehensive rehabilitation of cancer patients: A review |
(Rus)
|
|
Gameeva E.V., Stepanova A.M., Tkachenko G.A., Gridnev O.V., Sviridov S.V., Shestopalov A.E.
|
| Vol 18, No 1 (2016) |
Concerning selective neck dissections in oral squamous cell carcinoma |
(Rus)
|
|
Alymov Y.V., Podvyaznikov S.O., Mudunov A.M.
|
| Vol 25, No 4 (2023) |
Correction of lower limb lymphedema in patients with cervical cancer after combination treatment: A case report |
(Rus)
|
|
Obukhova O.A., Dibirova P.A., Kurmukov I.A., Allakhverdiyan G.S., Shagina N.Y., Mustafina E.А., Knyazev R.I., Pajanidi J.G.
|
| Vol 20, No 1 (2018) |
Cost-effectiveness analysis of ixabepilone use in monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin |
(Rus)
|
|
Kolbin A.S., Mosikyan A.A., Balykina Y.E., Proskurin M.A.
|
| Vol 18, No 2 (2016) |
Cost-effectiveness of empegfilgrastim (Extimia®) for the prevention of severe neutropenia in patients with malignant neoplasm of female breast |
(Rus)
|
|
Rudakova A.V., Tolkacheva D.G., Gavrilova O.N., Vaganov A.S.
|
| Vol 26, No 3 (2024) |
Cost-effectiveness of using granulocyte colony-stimulating factor in the treatment of uterine body leiomyosarcomas. A retrospective analysis |
(Rus)
|
|
Saevets V.V., Kuzmin N.K., Shamanova A.Y., Mukhin A.A., Taratonov A.V.
|
| Vol 24, No 2 (2022) |
Creating a story on the pages of a book about diffuse B-large cell lymphoma |
(Rus)
|
|
Editorial B.
|
| Vol 27, No 1 (2025) |
Cryoablation of prostate cancer: existing limitations and prospects for further development. A review |
(Rus)
|
|
Vasilyev A.O., Pushkarev A.V., Govorov A.V., Saakyan N.Y., Tsiganov D.I.
|
| Vol 25, No 3 (2023) |
CT sarcometry in the prediction of postoperative complications in patients with gastric cancer: Retrospective cohort study |
(Rus)
|
|
Agababyan T.A., Kukarskaya V.A., Silanteva N.K., Potapov A.L., Skoropad V.Y., Sheberova E.V., Dorozhkin A.D., Ivanov S.А., Kaprin A.D.
|
| Vol 14, No 2 (2012) |
Cubpopulyatsionnyy sostav i tsitokinsekretornaya funktsiya kletok produkta separatsii u bol'nykh limfomami |
|
|
Baranova D.S., Sakhno L.V., Kryuchkova I.V., Pronkina N.V., Batorov E.V., Tikhonova M.A., Gilevich A.V., Sergeevicheva V.V., Sizikova S.A., Ushakova G.Y., Ostanin A.A., Pospelova T.I., Chernykh E.R.
|
| Vol 15, No 1 (2013) |
CUP-syndrome: the present view of the problem (a review of literature) |
|
|
Levitskaya N.V., Lewitzki V., Komarov I.G., Nemtsova M.V., Poddubnaya I.V.
|
| Vol 16, No 3 (2014) |
Current algorhytm of screening and early diagnosis of hepatocellular carcinoma |
|
|
Tikhonov I.N., Pavlov C.S., Mayevskaya M.V., Ivashkin V.T.
|
| Vol 15, No 1 (2013) |
Current approach to adjuvant therapy for breast cancer (a review) |
|
|
Conte P., Guarneri V.
|
| Vol 24, No 2 (2022) |
Current concepts of neuroendocrine cancer of the prostate: a clinical case and review of the literature |
(Rus)
|
|
Chizh G.A., Tyutrina Y.A., Protsenko S.A., Dzhelialov E.S., Latipova D.H.
|
| Vol 17, No 4 (2015) |
Current possibilities in diagnosis and treatment of diffuse large B cell lymphoma in children and adolescents: results of Pediatric Hematology and Oncology Research Institute of N.N.Blokhin Russian Cancer Research Center, international experience |
|
|
Levashov A.S., Kovrigina A.M., Valiev T.T., Belyaeva E.S., Popa A.V., Mentkevich G.L.
|
| Vol 26, No 3 (2024) |
Current state of care for cancer patients with HIV in Russia: Data from an oncologist survey |
(Rus)
|
|
Levkovskiy O.V., Ivanov S.A., Falaleeva N.A., Galitsyna A.B., Syadrin M.G.
|
| Vol 26, No 3 (2024) |
Current technologies of response assessment in rectal cancer after neoadjuvant treatment: A review |
(Rus)
|
|
Orlov A.E., Kaganov O.I., Frolov S.A., Blinov N.V., Okulevich N.B.
|
| Vol 24, No 2 (2022) |
Current treatment aspects of hormone-dependent ERBB2-negative metastatic breast cancer: overall survival outcomes |
(Rus)
|
|
Snegovoy A.V., Kononenko I.B.
|
| Vol 18, No 5 (2016) |
Current treatment of chronic lymphocytic leukemia. New opportunities and new difficulties |
|
|
Samoylova O.S.
|
| Vol 17, No 3 (2015) |
Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer |
|
|
Knyazev R.I., Poddubnaya I.V., Barinov V.V., Bokin I.I.
|
| Vol 13, No 1 (2011) |
Dannye dolgosrochnogo nablyudeniya podtverzhdayut, chto razrabotannyy kompaniey Novartispreparat TasignaR prevoskhodit preparat GlivekR po snizheniyu riska progressirovaniyazabolevaniya u patsientov s vpervye diagnostirovannym khronicheskim mieloleykozom |
|
|
- -.
|
| Vol 11, No 4 (2009) |
Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade |
|
|
Lichinitser M.R., Semenov N.N.
|
| 101 - 200 of 1398 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> |
